Humans.ai, deep-tech company building the next-generation blockchain platform that brings together an ecosystem of stakeholders around the use of AI to create at scale, announces its partnership with Next Chymia Consulting HK, one of the main investors in the company and well known investment fund supporting commercial ventures that aim to revolutionize their industries, using blockchain technology.
We are very excited to have Next Chymia Consulting as our partner on this journey and we appreciate their investment in the company and their continued support. The team at Next Chymia Consulting has advised and helped expand numerous blockchain companies over the past few years. Blockchain has already become a technology disruptor that has impacted various business models, processes and supply chains. We at Humans.ai believe the AI market can have the greatest positive impact from the integration of blockchain given the challenges with control and transparency., said Sabin Dima, CEO at Humans.ai.
Asian based company, Next Chymia Consulting, invests in innovative startups which implement or help the use of blockchain technology, by also offering advice on the strategic employment of blockchain technology based on a thorough analysis of the companies’ profile.
The team at Next Chymia Consulting carefully assesses the potential of blockchain technology companies and helps support high potential ventures in the field. Additionally, Next Chymia Consulting offers companies support throughout the entire process of integration and adaptation of blockchain technology into already existing networks.
Humans.ai is developing the first framework for ethical AI and blockchain. It is creating an all-in-one platform for AI-based creation and governance at scale, beginning with an initial focus on synthetic media. Through its creative studio and token-based ownership and accountability system, Humans.ai is designed to ensure contributions are fairly rewarded and that every AI is kept honest over the long term.
Thus, Humans.ai is building the next-generation blockchain platform that brings together an ecosystem of stakeholders around the use of AI to create at scale. It combines a library of AI tools into a creative studio suite where users will be able to pick and choose as they bring their ideas to life. Individuals are empowered to create and own their digital likenesses, which may be used by themselves and others in the creation of any number of digital assets. The synthetic media, AI apps, and other digital assets utilize blockchain technology to generate Non-Fungible Tokens (NFTs) as a way of creating transparency, provenance, accountability, and long-term governance.
Thus, the Humans.ai company empowers people to raise, control, and own AI, combining the power of blockchain with Artificial Intelligence, in order to allow anyone anywhere to create at scale.
About Next Chymia Consulting
Next Chymia Consulting is an Asian based company that provides blockchain solutions, consultancy services and training to global entities. Next Chymia Consulting provides high potential ventures with the programming of scalable and distributed applications and custom-built protocols.
TheNext Chymia Consulting international network of Blockchain technology and financial services makes use of its international network and provides consulting service to the worldwide.
Humans.ai is a Web 3.0 company that brings together an ecosystem of stakeholders around the use of AI to create at scale. Introducing the first framework for ethical AI and blockchain, Humans.ai is creating an all-in-one platform for AI-based creation and governance. Through its creative studio, token-based ownership and accountability system, Humans.ai is designed to ensure contributions are fairly rewarded and that every AI is kept honest over the long term.
The native token of the Humans.ai ecosystem, the $HEART token, empowers users to participate in the governance of the platform and facilitates key flows of value within it. All fees charged within the Humans.ai platform will be paid in $HEART.